share_log

MEDIROM Healthcare Technologies | 6-K: Report of foreign private issuer (related to financial reporting)

MEDIROM Healthcare Technologies | 6-K: Report of foreign private issuer (related to financial reporting)

MEDIROM Healthcare Technologies | 6-K:外國發行人報告(業績相關)
美股SEC公告 ·  2024/06/25 19:05

Moomoo AI 已提取核心訊息

MEDIROM Healthcare Technologies reported net profit of JPY115 million for FY2023, despite significant investment in healthcare technology systems. Revenue slightly decreased 1.8% to JPY6.83 billion, while Adjusted EBITDA reached JPY306 million with a 4.5% margin.The Relaxation Salon segment saw 1.5% revenue growth to JPY6.06 billion, driven by increased sales per customer to JPY6,852. The company sold 30 salons to investors in 2023 under its sale-and-outsource model. Digital Preventative Healthcare revenue declined 48.1% to JPY200 million due to delays in REMONY system development.The company maintained profitability while advancing its healthcare technology initiatives, including the launch of REMONY Monitoring System. As of May 2024, MEDIROM operates 307 relaxation salons across Japan and has contracts with 81 corporate insurance associations for its Lav health guidance program, serving over 7,200 users.
MEDIROM Healthcare Technologies reported net profit of JPY115 million for FY2023, despite significant investment in healthcare technology systems. Revenue slightly decreased 1.8% to JPY6.83 billion, while Adjusted EBITDA reached JPY306 million with a 4.5% margin.The Relaxation Salon segment saw 1.5% revenue growth to JPY6.06 billion, driven by increased sales per customer to JPY6,852. The company sold 30 salons to investors in 2023 under its sale-and-outsource model. Digital Preventative Healthcare revenue declined 48.1% to JPY200 million due to delays in REMONY system development.The company maintained profitability while advancing its healthcare technology initiatives, including the launch of REMONY Monitoring System. As of May 2024, MEDIROM operates 307 relaxation salons across Japan and has contracts with 81 corporate insurance associations for its Lav health guidance program, serving over 7,200 users.
MEDIROm醫療科技公司發佈了2024年5月的關鍵業績因數。總體用戶數同比從86,895減少到80,512,而每位用戶的銷售額從6,660日元增加到6,964日元。公司經營了307家美容院,比2023年5月的314家有所下降,重複消費比例略微減少至74.8%,低於75.7%。在其健康科技業務中,MEDIROM的Lav®應用於特定健康指導項目,截至2024年5月已與81家企業保險協會簽約,較一年前的68家有所增加。Lav®用戶數累計達7,238,顯示出這一領域的穩定增長。MEDIROm繼續多元化其醫療服務,包括在2023年推出的REMONY,遠程監控系統針對企業客戶。公司旨在利用其多樣化的健康相關產品和服務來收集和管理醫療數據,確立其在醫療行業大數據領域的領導地位。
MEDIROm醫療科技公司發佈了2024年5月的關鍵業績因數。總體用戶數同比從86,895減少到80,512,而每位用戶的銷售額從6,660日元增加到6,964日元。公司經營了307家美容院,比2023年5月的314家有所下降,重複消費比例略微減少至74.8%,低於75.7%。在其健康科技業務中,MEDIROM的Lav®應用於特定健康指導項目,截至2024年5月已與81家企業保險協會簽約,較一年前的68家有所增加。Lav®用戶數累計達7,238,顯示出這一領域的穩定增長。MEDIROm繼續多元化其醫療服務,包括在2023年推出的REMONY,遠程監控系統針對企業客戶。公司旨在利用其多樣化的健康相關產品和服務來收集和管理醫療數據,確立其在醫療行業大數據領域的領導地位。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息